A new Covid vaccine is likely to be needed by next year to protect people from future mutations of the coronavirus, said the head of BioNTech SE, the German company that developed the first Covid vaccine.
Ugur Sahin, co-founder and chief executive officer of BioNtech, has said that current variants of Covid, such as the delta strain, are not different enough to undermine current vaccinations. However, new strains will emerge that can evade booster shots and the body’s immune defenses, Sahin told Financial Times.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.